Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re‐expressing the epigenetically repressed tumor suppressor—estrogen receptor β
1. Division of Endocrinology, CSIR‐Central Drug Research Institute, Lucknow, India;2. Division of Medicinal and Process Chemistry, CSIR‐Central Drug Research Institute, Lucknow, India